Microbiological Testing of Water Market Forecasts to 2030 – Global Analysis By Product Type (Testing Kits, Filters and Membranes, Instruments and Other Product Types), Pathogen Type (Coliform, Vibrio, Legionella, Clostridium, Salmonella and Other Pathogen

Microbiological Testing of Water Market Forecasts to 2030 – Global Analysis By Product Type (Testing Kits, Filters and Membranes, Instruments and Other Product Types), Pathogen Type (Coliform, Vibrio, Legionella, Clostridium, Salmonella and Other Pathogen Types), Water Type, End User and by Geography

According to Stratistics MRC, the Global Microbiological Testing of Water Market is accounted for $1.96 billion in 2024 and is expected to reach $3.36 billion by 2030 growing at a CAGR of 9.4% during the forecast period. Microbiological testing of water is a critical process used to assess water quality and ensure it is safe for human consumption, industrial use, and environmental protection. This testing entails identifying and measuring microorganisms that can cause waterborne illnesses and present significant health risks, including bacteria, viruses, and protozoa. Important markers, such as coliform bacteria and Escherichia coli (E. coli), are frequently tracked because they may indicate contamination from feces or other dangerous sources. Moreover, microbiological water testing is crucial in environments where strict quality standards are required, such as municipal water systems and food and beverage production.

According to the Environmental Protection Agency (EPA), the Safe Drinking Water Act mandates that public water systems perform regular microbiological testing for contaminants such as coliform bacteria, as part of efforts to protect over 300 million Americans who rely on public drinking water systems.

Market Dynamics:

Driver:

Increasing knowledge of waterborne illnesses

Public awareness of the significance of water quality has increased as a result of the rising prevalence of waterborne illnesses worldwide. Particularly in susceptible groups, diseases like cholera, typhoid fever, and hepatitis A can have catastrophic health consequences. The need for microbiological testing to guarantee that drinking water is safe and pathogen-free is growing as communities become more aware of these dangers. Additionally, this increased awareness is also a result of health initiatives and educational campaigns that try to prevent disease outbreaks.

Restraint:

High testing costs

The high expense of testing methods and equipment is one of the main barriers to the market for microbiological testing of water. Although they require a large initial investment, advanced technologies like flow cytometry and polymerase chain reaction (PCR) provide increased speed and accuracy. Smaller businesses and organizations might find it difficult to pay for these pricey testing solutions, especially in developing nations. As a result, market participation may be restricted and adoption rates may be slower. Furthermore, investment in microbiological testing facilities may be discouraged by the continued maintenance and calibration of complex testing apparatus, which raises operating costs even more.

Opportunity:

Demand for monitoring solutions in real time

Growing water safety awareness and the need for rapid response mechanisms to contamination events have led to an increase in demand for real-time monitoring solutions. Technologies are being developed to improve data accuracy and expedite the testing process, including AI-driven analytics and automated testing devices. To increase throughput and decrease errors, automated systems, for example, can gather and analyze water samples with little assistance from humans. Moreover, besides improving public health and safety, this move to real-time monitoring also complies with legal mandates for prompt reporting of water quality problems.

Threat:

Changing character of microorganisms

The constantly changing nature of microorganisms is one of the biggest threats to the market for microbiological testing. Because pathogens are always changing and adapting, new strains may appear that are difficult for current testing methods to identify. This calls for constant testing method adaptation and improvement, which can be expensive and resource-intensive for labs and testing facilities. Additionally, failure to adapt to these changes may lead to contamination that goes unnoticed, endangering public health and eroding trust in test results.

Covid-19 Impact:

COVID-19 has had a complex effect on the market for microbiological testing of water, posing both opportunities and challenges. Initially, the pandemic disrupted laboratory and supply chain operations, leading to delays in testing services and a backlog of water quality assessments. However, the pandemic's increased focus on health and safety led to a sharp rise in public anxiety about water quality, which in turn fuelled demand for microbiological testing as people looked for guarantees regarding the safety of their drinking water. In reaction to the pandemic, regulatory agencies also increased their scrutiny of water quality standards, which helped to drive the market.

The Coliform segment is expected to be the largest during the forecast period

The market for microbiological testing of water is expected to be the largest share in the coliform segment. Testing for coliform bacteria is essential to guaranteeing safe drinking water because they are frequently used as an indicator of water quality and possible contamination. Numerous tests are conducted on both public and private water supplies because the presence of coliforms raises the possibility of the presence of other dangerous pathogens. Moreover, the coliform segment is anticipated to continue to hold its market leadership as public awareness of waterborne illnesses rises and regulatory frameworks become stricter, highlighting its critical role in microbial water quality assessment.

The Pharmaceutical and Biotechnology segment is expected to have the highest CAGR during the forecast period

The pharmaceutical and biotechnology segment is anticipated to grow at the highest CAGR. The strict regulatory requirements for water quality in pharmaceutical manufacturing processes, where purity and contamination control are crucial, are the main driver of this growth. Since any microbial contamination can jeopardize patient safety and product integrity, the pharmaceutical industry mainly depends on microbiological testing to make sure that water used in drug production satisfies safety standards. Additionally, a stronger emphasis on quality control measures, such as stringent testing procedures for water used in production and research, has also resulted from the growing interest in biopharmaceuticals and personalized medicine.

Region with largest share:

Due to its established infrastructure and strict regulations pertaining to water safety and quality, the North American region commands the largest share of the market for microbiological testing of water. Strong compliance requirements for microbiological testing across a range of sectors, including municipal water supplies, food and beverage, and pharmaceuticals, reflect the importance of ensuring safe drinking water in this developed market. Furthermore, the region's dominance is also a result of its highly developed technological capabilities, as businesses consistently invest in cutting-edge testing techniques to improve efficiency and accuracy.

Region with highest CAGR:

The market for microbiological testing of water is expected to grow at the highest CAGR in the Europe region due to the growing need for microbiological testing equipment and kits in a variety of industries, especially in the food and beverage, pharmaceutical, and industrial processes sectors. Reliable testing solutions are more important than ever because of the European Medicines Agency's (EMA) stringent compliance requirements for water quality in pharmaceutical production. Moreover, the EU's efforts to increase access to clean drinking water and increased public awareness of water safety are driving market expansion.

Key players in the market

Some of the key players in Microbiological Testing of Water market include 3M Company, Agilent Technologies, Inc, Charles River Laboratories, Inc., IDEXX Laboratories, Inc., Thermo Fisher Scientific, Inc., Avantor Inc., Merck KGaA, Shimadzu Corporation, LaMotte Company, Danaher Corporation, Bio-Rad Laboratories Inc., Perkinelmer, Inc, Accepta Ltd, Döhler Group and Eurofins Scientific SE.

Key Developments:

In August 2024, Avantor has announced a definitive agreement to divest its clinical services business to Audax Private Equity for approximately $650 million. This strategic move aims to optimize Avantor's portfolio and sharpen its focus on lab and production businesses. The transaction, expected to close in Q4 2024, will generate about $475 million in after-tax cash proceeds, which will be used for debt paydown.

In July 2024, Agilent Technologies Inc. announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturing organization, for $925 million. Based in Canada, BIOVECTRA produces biologics, highly potent active pharmaceutical ingredients, and other molecules for targeted therapeutics.

In February 2023, Thermo Fisher Scientific Inc. entered into a definitive agreement to acquire CorEvitas, a provider of regulatory-grade, real-world evidence for approved medical treatments and therapies, from Audax Private Equity, for $912.5 million in cash. CorEvitas will become part of Thermo Fisher's Laboratory Products and Biopharma Services segment. The transaction is expected to be completed by the end of 2023.

Product Types Covered:
• Testing Kits
• Filters and Membranes
• Instruments
• Other Product Types

Pathogen Types Covered:
• Coliform
• Vibrio
• Legionella
• Clostridium
• Salmonella
• Other Pathogen Types

Water Types Covered:
• Drinking and Bottled Water
• Industrial Water

End Users Covered:
• Food & Beverage (F&B) Industry
• Pharmaceutical and Biotechnology
• Hospitals and Healthcare
• Industrial Process
• Environmental
• Chemicals and Materials
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances